VTR Ventas, Inc.
Ventas, Inc. is an S&P 500 company enabling exceptional environments that benefit a large and growing aging population. With approximately 1,450 properties in North America and the United Kingdom, Ventas occupies an essential role in the longevity economy. The Company's growth is fueled by its more than 900 senior housing communities, which provide valuable services to residents and enable them to thrive in supported environments. Ventas aims to deliver outsized performance by leveraging its operational expertise, data-driven insights from its Ventas OITM platform, extensive relationships and strong financial position. The Ventas portfolio also includes outpatient medical buildings, research centers and healthcare facilities. Ventas, Inc. is based in Illinois, Chicago. Ventas, Inc. was incorporated in 1983 in Maryland.…
Industry Peers
REIT - Healthcare FacilitiesKey Statistics
About Ventas (NYSE: VTR)
›
Ventas (NYSE: VTR) is listed on the New York Stock Exchange, where its shares trade in USD. It belongs to the REIT - Healthcare Facilities industry, part of the Real Estate sector, and reports about 542 employees.
The shares were at 87.00 USD on 19 November 2026, up 12.9% over 52 weeks. Its 52-week range is 73.82 USD to 101.60 USD: the price is 14.4% below the high and 17.9% above the low.
At a market capitalisation of 46.01B USD, it trades at 167.3 times trailing earnings and 138.1 times forward earnings. The median trailing P/E of its 15 largest REIT - Healthcare Facilities peers is 23.3, a premium of 619% for VTR. It pays a dividend yielding 2.36%, against a median of 5.78% among the dividend payers in that peer group.
Ventas reports return on equity of 2.0%, an operating margin of 14.6% and revenue up 21.5% year over year.
Its debt exceeds its cash by 12.47B USD, a debt-to-equity ratio of 1.06. Its Piotroski F-score is 6 out of 9, an average reading of its financial health. 22 analysts cover the stock, with an average rating of Buy; their mean price target of 99.77 USD is 14.7% above the current price. The next earnings report is expected on 3 February 2027.